Global Corticosteroid Injections for Joint Pain Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Knee & Ankle
Hip Joint
Shoulder & Elbow
Facet Joints of the Spine
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet
SEIKAGAKU
Chugai Pharma

Table of Content
1 Corticosteroid Injections for Joint Pain Market Overview
1.1 Product Overview and Scope of Corticosteroid Injections for Joint Pain
1.2 Corticosteroid Injections for Joint Pain Segment by Type
1.2.1 Global Corticosteroid Injections for Joint Pain Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Knee & Ankle
1.2.3 Hip Joint
1.2.4 Shoulder & Elbow
1.2.5 Facet Joints of the Spine
1.2.6 Others
1.3 Corticosteroid Injections for Joint Pain Segment by Application
1.3.1 Corticosteroid Injections for Joint Pain Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Corticosteroid Injections for Joint Pain Market Size Estimates and Forecasts
1.4.1 Global Corticosteroid Injections for Joint Pain Revenue 2016-2027
1.4.2 Global Corticosteroid Injections for Joint Pain Sales 2016-2027
1.4.3 Corticosteroid Injections for Joint Pain Market Size by Region: 2016 Versus 2021 Versus 2027
2 Corticosteroid Injections for Joint Pain Market Competition by Manufacturers
2.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2016-2021)
2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Corticosteroid Injections for Joint Pain Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Corticosteroid Injections for Joint Pain Manufacturing Sites, Area Served, Product Type
2.5 Corticosteroid Injections for Joint Pain Market Competitive Situation and Trends
2.5.1 Corticosteroid Injections for Joint Pain Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Corticosteroid Injections for Joint Pain Players Market Share by Revenue
2.5.3 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Corticosteroid Injections for Joint Pain Retrospective Market Scenario by Region
3.1 Global Corticosteroid Injections for Joint Pain Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Corticosteroid Injections for Joint Pain Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.3.1 North America Corticosteroid Injections for Joint Pain Sales by Country
3.3.2 North America Corticosteroid Injections for Joint Pain Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.4.1 Europe Corticosteroid Injections for Joint Pain Sales by Country
3.4.2 Europe Corticosteroid Injections for Joint Pain Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Corticosteroid Injections for Joint Pain Market Facts & Figures by Region
3.5.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region
3.5.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.6.1 Latin America Corticosteroid Injections for Joint Pain Sales by Country
3.6.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Corticosteroid Injections for Joint Pain Market Facts & Figures by Country
3.7.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country
3.7.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Corticosteroid Injections for Joint Pain Historic Market Analysis by Type
4.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2016-2021)
4.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2016-2021)
4.3 Global Corticosteroid Injections for Joint Pain Price by Type (2016-2021)
5 Global Corticosteroid Injections for Joint Pain Historic Market Analysis by Application
5.1 Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2016-2021)
5.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2016-2021)
5.3 Global Corticosteroid Injections for Joint Pain Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Allergan Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Anika Therapeutics
6.4.1 Anika Therapeutics Corporation Information
6.4.2 Anika Therapeutics Description and Business Overview
6.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Anika Therapeutics Product Portfolio
6.4.5 Anika Therapeutics Recent Developments/Updates
6.5 Ferring
6.5.1 Ferring Corporation Information
6.5.2 Ferring Description and Business Overview
6.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Ferring Product Portfolio
6.5.5 Ferring Recent Developments/Updates
6.6 Bioventus
6.6.1 Bioventus Corporation Information
6.6.2 Bioventus Description and Business Overview
6.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bioventus Product Portfolio
6.6.5 Bioventus Recent Developments/Updates
6.7 Flexion Therapeutics
6.6.1 Flexion Therapeutics Corporation Information
6.6.2 Flexion Therapeutics Description and Business Overview
6.6.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Flexion Therapeutics Product Portfolio
6.7.5 Flexion Therapeutics Recent Developments/Updates
6.8 Zimmer Biomet
6.8.1 Zimmer Biomet Corporation Information
6.8.2 Zimmer Biomet Description and Business Overview
6.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Zimmer Biomet Product Portfolio
6.8.5 Zimmer Biomet Recent Developments/Updates
6.9 SEIKAGAKU
6.9.1 SEIKAGAKU Corporation Information
6.9.2 SEIKAGAKU Description and Business Overview
6.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.9.4 SEIKAGAKU Product Portfolio
6.9.5 SEIKAGAKU Recent Developments/Updates
6.10 Chugai Pharma
6.10.1 Chugai Pharma Corporation Information
6.10.2 Chugai Pharma Description and Business Overview
6.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Chugai Pharma Product Portfolio
6.10.5 Chugai Pharma Recent Developments/Updates
7 Corticosteroid Injections for Joint Pain Manufacturing Cost Analysis
7.1 Corticosteroid Injections for Joint Pain Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Corticosteroid Injections for Joint Pain
7.4 Corticosteroid Injections for Joint Pain Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Corticosteroid Injections for Joint Pain Distributors List
8.3 Corticosteroid Injections for Joint Pain Customers
9 Corticosteroid Injections for Joint Pain Market Dynamics
9.1 Corticosteroid Injections for Joint Pain Industry Trends
9.2 Corticosteroid Injections for Joint Pain Growth Drivers
9.3 Corticosteroid Injections for Joint Pain Market Challenges
9.4 Corticosteroid Injections for Joint Pain Market Restraints
10 Global Market Forecast
10.1 Corticosteroid Injections for Joint Pain Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Corticosteroid Injections for Joint Pain by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Corticosteroid Injections for Joint Pain by Type (2022-2027)
10.2 Corticosteroid Injections for Joint Pain Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Corticosteroid Injections for Joint Pain by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Corticosteroid Injections for Joint Pain by Application (2022-2027)
10.3 Corticosteroid Injections for Joint Pain Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Corticosteroid Injections for Joint Pain by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Corticosteroid Injections for Joint Pain by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer